By investing in the CMTA’s Legacy Society, you can ensure that children with CMT will grow up with the hope of a world without CMT. The 2023 Spring CMTA Report (182 downloads) VIEW IN BROWSER In addition to our regular features, this issue of The CMTA Report is packed with these articles and items of interest: New CMT1X Mouse Model Patients as Partners in Research Tour of Conklin Lab Life-Changing Pharnext Moves Px3003 Production to Us ASO Treatment for CMT1A Circumnavigating the Globe New CMTA Board Member Sholarships for Students with Rare Disease